Abuse Liability of Buprenorphine vs. Buprenorphine/Naloxone: Importance of Absolute Amount

被引：0
|
作者：
Jones, Jermaine [1 ]
机构：
[1] Columbia Univ, Med Ctr, Div Subst Abuse, New York, NY USA
来源：
BIOLOGICAL PSYCHIATRY | 2016年 / 79卷 / 09期
关键词：
Buprenorphine; Opioid Abuse; Naloxone; Abuse Liability; Behavioral Pharmacology;
D O I：
暂无
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
739
引用
收藏
页码：263S / 264S
页数：2
相关论文
共 50 条
  • [1] Abuse liability of intravenous buprenorphine vs. buprenorphine/naloxone: Importance of absolute naloxone amount
    Jones, Jermaine D.
    Manubay, Jeanne M.
    Mogali, Shanthi
    Metz, Verena E.
    Madera, Gabriela
    Martinez, Suky
    Mumtaz, Mudassir
    Comer, Sandra D.
    [J]. DRUG AND ALCOHOL DEPENDENCE, 2017, 179 : 362 - 369
  • [2] Abuse liability of intravenous buprenorphine/naloxone and buprenorphine alone in buprenorphine-maintained intravenous heroin abusers
    Comer, Sandra D.
    Sullivan, Maria A.
    Vosburg, Suzanne K.
    Manubay, Jeanne
    Amass, Leslie
    Cooper, Ziva D.
    Saccone, Phillip
    Kleber, Herbert D.
    [J]. ADDICTION, 2010, 105 (04) : 709 - 718
  • [3] Abuse Potential of Intranasal Buprenorphine vs Buprenorphine/Naloxone in Buprenorphine-maintained Heroin Users
    Jones, Jermaine D.
    Sullivan, Maria A.
    Manubay, Jeanne M.
    Mogali, Shanthi
    Metz, Verena
    Comer, Sandra D.
    [J]. NEUROPSYCHOPHARMACOLOGY, 2013, 38 : S515 - S516
  • [4] Abuse liability of intravenous buprenorphine, the buprenorphine/naloxone combination, and methadone in recently detoxified heroin abusers
    Comer, S. D.
    Sullivan, M. A.
    Collins, E. D.
    Fischman, M. W.
    [J]. DRUG AND ALCOHOL DEPENDENCE, 2006, 83 : S85 - S85
  • [5] Buprenorphine/Naloxone vs. Buprenorphine for Medication Assisted Therapy of Opioid Use Disorder in Pregnancy
    Johnson, Quinetta
    O'Brien, John M.
    Hawk, Greg
    Qi, Ya
    Critchfield, Agatha
    [J]. OBSTETRICS AND GYNECOLOGY, 2019, 133 : 93S - 93S
  • [6] Abuse liability of intravenous buprenorphine/naloxone and buprenorphine alone in buprenorphine-maintained intravenous heroin abusers (vol 105, pg 706, 2009)
    Comer, Sandra D.
    Sullivan, Maria A.
    Vosburg, Suzanne K.
    Manubay, Jeanne
    Amass, Leslie
    Cooper, Ziva D.
    Saccone, Phillip
    Kleber, Herbert D.
    [J]. ADDICTION, 2010, 105 (07) : 1322 - 1322
  • [7] Abuse liability of buprenorphine-naloxone tablets in untreated IV drug users
    Alho, Hannu
    Sinclair, David
    Vuori, Erkki
    Holopainen, Antti
    [J]. DRUG AND ALCOHOL DEPENDENCE, 2007, 88 (01) : 75 - 78
  • [8] Abuse potential of intranasal buprenorphine versus buprenorphine/naloxone in buprenorphine-maintained heroin users
    Jones, Jermaine D.
    Sullivan, Maria A.
    Vosburg, Suzanne K.
    Manubay, Jeanne M.
    Mogali, Shanthi
    Metz, Verena
    Comer, Sandra D.
    [J]. ADDICTION BIOLOGY, 2015, 20 (04) : 784 - 798
  • [9] Comparative Safety of In Utero Exposure to Buprenorphine Combined With Naloxone vs Buprenorphine Alone
    Straub, Loreen
    Bateman, Brian T.
    Hernandez-Diaz, Sonia
    Zhu, Yanmin
    Suarez, Elizabeth A.
    Vine, Seanna M.
    Jones, Hendree E.
    Connery, Hilary S.
    Davis, Jonathan M.
    Gray, Kathryn J.
    Lester, Barry
    Terplan, Mishka
    Zakoul, Heidi
    Mogun, Helen
    Huybrechts, Krista F.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2024,
  • [10] Parenteral buprenorphine-naloxone abuse is a major cause of fatal buprenorphine-related poisoning
    Hakkinen, Margareeta
    Heikman, Pertti
    Ojanpera, Ilkka
    [J]. FORENSIC SCIENCE INTERNATIONAL, 2013, 232 (1-3) : 11 - 15
12345